Literature DB >> 22484394

Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidase.

Karol Kaszuba1, Tomasz Róg, Reinis Danne, Peter Canning, Vilmos Fülöp, Tünde Juhász, Zoltán Szeltner, J-F St Pierre, Arturo García-Horsman, Pekka T Männistö, Mikko Karttunen, Jyrki Hokkanen, Alex Bunker.   

Abstract

Altered prolyl oligopeptidase (PREP) activity is found in many common neurological and other genetic disorders, and in some cases PREP inhibition may be a promising treatment. The active site of PREP resides in an internal cavity; in addition to the direct interaction between active site and substrate or inhibitor, the pathway to reach the active site (the gating mechanism) must be understood for more rational inhibitor design and understanding PREP function. The gating mechanism of PREP has been investigated through molecular dynamics (MD) simulation combined with crystallographic and mutagenesis studies. The MD results indicate the inter-domain loop structure, comprised of 3 loops at residues, 189-209 (loop A), 577-608 (loop B), and 636-646 (loop C) (porcine PREP numbering), are important components of the gating mechanism. The results from enzyme kinetics of PREP variants also support this hypothesis: When loop A is (1) locked to loop B through a disulphide bridge, all enzyme activity is halted, (2) nicked, enzyme activity is increased, and (3) removed, enzyme activity is only reduced. Limited proteolysis study also supports the hypothesis of a loop A driven gating mechanism. The MD results show a stable network of H-bonds that hold the two protein domains together. Crystallographic study indicates that a set of known PREP inhibitors inhabit a common binding conformation, and this H-bond network is not significantly altered. Thus the domain separation, seen to occur in lower taxa, is not involved in the gating mechanism for mammalian PREP. In two of the MD simulations we observed a conformational change that involved the breaking of the H-bond network holding loops A and B together. We also found that this network was more stable when the active site was occupied, thus decreasing the likelihood of this transition.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484394     DOI: 10.1016/j.biochi.2012.03.012

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  13 in total

1.  Carboxypeptidase in prolyl oligopeptidase family: Unique enzyme activation and substrate-screening mechanisms.

Authors:  Pooja Yadav; Venuka Durani Goyal; Neeraj Kailash Gaur; Ashwani Kumar; Sadashiv M Gokhale; Sahayog N Jamdar; Ravindra D Makde
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

2.  Unveiling prolyl oligopeptidase ligand migration by comprehensive computational techniques.

Authors:  Martin Kotev; Daniel Lecina; Teresa Tarragó; Ernest Giralt; Víctor Guallar
Journal:  Biophys J       Date:  2015-01-06       Impact factor: 4.033

3.  Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors.

Authors:  Tommi P Kilpeläinen; Jonna K Tyni; Maija K Lahtela-Kakkonen; Tony S Eteläinen; Timo T Myöhänen; Erik A A Wallén
Journal:  ACS Med Chem Lett       Date:  2019-11-11       Impact factor: 4.345

Review 4.  NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness.

Authors:  Nicholas J Bradshaw; Mirian A F Hayashi
Journal:  Cell Mol Life Sci       Date:  2016-10-14       Impact factor: 9.261

5.  Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.

Authors:  Mari H Savolainen; Xu Yan; Timo T Myöhänen; Henri J Huttunen
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

6.  Crystal Structure and Conformational Dynamics of Pyrococcus furiosus Prolyl Oligopeptidase.

Authors:  Ken Ellis-Guardiola; Huan Rui; Ryan L Beckner; Poonam Srivastava; Narayanasami Sukumar; Benoît Roux; Jared C Lewis
Journal:  Biochemistry       Date:  2019-03-05       Impact factor: 3.162

7.  Engineering a dirhodium artificial metalloenzyme for selective olefin cyclopropanation.

Authors:  Poonam Srivastava; Hao Yang; Ken Ellis-Guardiola; Jared C Lewis
Journal:  Nat Commun       Date:  2015-07-24       Impact factor: 14.919

Review 8.  Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.

Authors:  I M D Bastos; F N Motta; P Grellier; J M Santana
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  Targeting prolyl endopeptidase with valproic acid as a potential modulator of neutrophilic inflammation.

Authors:  Mojtaba Abdul Roda; Mariam Sadik; Amit Gaggar; Matthew T Hardison; Michael J Jablonsky; Saskia Braber; James Edwin Blalock; Frank A Redegeld; Gert Folkerts; Patricia L Jackson
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

10.  Crystal structures of Trypanosoma brucei oligopeptidase B broaden the paradigm of catalytic regulation in prolyl oligopeptidase family enzymes.

Authors:  Peter Canning; Dean Rea; Rory E Morty; Vilmos Fülöp
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.